Gateway 2011: Hospira One 2 One - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Hospira One 2 One



Your online Gateway to Hospira One 2 One in 2011

275 North Field Drive
Lake Forest, Illinois, U.S.A. 60045
Call +1-224-212-2267



Don't miss Hospira One 2 One at BIO 2011, June 27-30, Washington, D.C.

About Hospira One 2 One

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to developing, manufacturing and marketing healthcare products that help improve the productivity, safety and efficacy of patient care. The company’s One 2 One business is a world leader in the custom development and manufacture of sterile injectable products packaged in vials, prefilled syringes, cartridges, flexible containers and ampules.

We offer product development and contract manufacturing services at our nine worldwide facilities. Whether your product is a small molecule or advanced biologic, our highly qualified personnel in every world-class facility ensure quality, capacity and security of supply.

Visit our Stand: 4640

We would like to invite you to meet us at stand 4640 to discuss partnering and business development opportunities. 

 

For more information:

one2one@hospira.com

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here